DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



[Efficacy evaluation of lafutidine for mild reflux esophagitis in Japanese patients].

Author(s): Ohara S, Haruma K, Kinoshita Y, Kusano M

Affiliation(s): Department of Gastroenterology, Tohoku Rosai Hospital, Japan. sohara1122@tohokuh.rofuku.go.jp

Publication date & source: 2010-04, Nihon Shokakibyo Gakkai Zasshi., 107(4):588-97.

Publication type: Comparative Study; English Abstract; Multicenter Study; Randomized Controlled Trial

To evaluate the efficacy of lafutidine (20mg) , famotidine (40mg) and placebo in patients with mild reflux esophagitis (Grades A and B according to the Los Angeles classification) , a double-blind, multicenter, randomized clinical trial was performed for the first time in Japanese patients. In addition to each physician's evaluation, efficacy was evaluated by judging panels using images submitted by each physician. The healing rate after 8 weeks for lafutidine, famotidine and placebo were 67.7%, 56.6% and 41.2%, respectively. Lafutidine was significantly more effective than placebo (p=0.002, according to the judging panels) . Based on the evaluation of endoscopic images by the judging panels, 91 (27.1%) of 336 images submitted by each physician were judged to not be mucosal breaks. Judging panels are considered one of the ways to resolve the problem of the need to unify the criteria.

Page last updated: 2011-12-09

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017